Barely two years after its operational launch, the Unified Patent Court (“UPC”) has already begun shaping a transnational doctrine of patent infringement by equivalence. Between late 2024 and mid-2025, four landmark first-instance decisions — Plant-e v Bioo (The Hague LD), Brussels LD CFI 376/2023, Mannheim LD CFI 471/2023, and N.J. Diffusion v Gisela Mayer (Paris LD) — established, refined, and finally harmonised the analytical framework for assessing functional equivalence…
»
In light of the amendments made in the Regulation on the Procedures and Principles Regarding the Monitoring of Transactions Affecting Foreign Exchange Positions by the Central Bank of the Republic of Türkiye (“Regulation”)on 3 May 2025, the criteria for companies subject to reporting obligations have been revised along with the reporting periods. This development has created a need to re-evaluate the reporting obligation, its scope and other practical issues relating to the…
»
With the decision of the Personal Data Protection Board dated 04.09.2025 and numbered 2025/1572, which entered into force by being published in the Official Gazette on 01.10.2025, the scope of data controllers exempt from the obligation to register with the Data Controllers’ Registry (VERBİS) has been amended.
Previously, data controllers whose main activity involved processing special categories of personal data were subject to the VERBİS registration obligation. However…
»
Mutlu Yıldırım Köse and Begüm Soydan report on a case in Turkey concerning the registration of the trade mark Clindoxyl and its use to threaten infringement proceedings against the genuine right holder, in which the courts protected the rightful owner and invalidated the bad faith registration.
Background
The dispute concerned the bad faith registration of a trade mark that had previously been registered in Türkiye in the name of Stiefel Laboratoires, Inc., an affiliate of…
»
The Law No. 7557 on the “Amendments to Certain Laws Related to Health and to the Decree Law No. 663”, which entered into force on 24 July 2025, introduced numerous changes that directly affect the healthcare sector. One of these changes is the Additional Article 20, which was added to the Basic Law on Health Services. This article aims to address critical areas such as the placement of counterfeit medical devices on the market, unauthorized sales and technical service…
»
On 2 July 2025, the Enlarged Board of Appeal of the European Patent Office (“EPO”), in its decision G 1/23, clarified whether a product already placed on the market, but whose internal structure cannot be analysed or reproduced by the skilled person, may nevertheless be excluded from the state of the art in the assessment of inventive step. In doing so, the Board added a new dimension to the ongoing debate following decision G 1/92.
The dispute giving rise to the decision…
»
